1 |
Dual factor delivery of CXCL12 and Exendin-4 for improved survival and function of encapsulated beta cells under hypoxic conditions Duncanson S, Sambanis A Biotechnology and Bioengineering, 110(8), 2292, 2013 |
2 |
Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells Durvasula K, Thule PM, Sambanis A Biotechnology and Bioengineering, 109(4), 1074, 2012 |
3 |
Dual Perfluorocarbon Method to Noninvasively Monitor Dissolved Oxygen Concentration in Tissue Engineered Constructs in vitro and in vivo Goh F, Long R, Simpson N, Sambanis A Biotechnology Progress, 27(4), 1115, 2011 |
4 |
Development and Characterization of a Tissue Engineered Pancreatic Substitute Based on Recombinant Intestinal Endocrine L-Cells Bara H, Sambanis A Biotechnology and Bioengineering, 103(4), 828, 2009 |
5 |
Insulin-secreting L-cells for the treatment of insulin-dependent diabetes Bara H, Sambanis A Biochemical and Biophysical Research Communications, 371(1), 39, 2008 |
6 |
Monitoring of dissolved oxygen and cellular bioenergetics within a pancreatic substitute Gross JD, Long RC, Constantinidis I, Sambanis A Biotechnology and Bioengineering, 98(1), 261, 2007 |
7 |
Use of glucose-responsive material to regulate insulin release from constitutively secreting cells Cheng SY, Constantinidis I, Sambanis A Biotechnology and Bioengineering, 93(6), 1079, 2006 |
8 |
Proteasome modulating agents induce rAAV2-mediated transgene expression in human intestinal epithelial cells Tang SC, Sambanis A, Sibley E Biochemical and Biophysical Research Communications, 331(4), 1392, 2005 |
9 |
Magnetically labeled insulin-secreting cells Oca-Cossio J, Mao H, Khokhlova N, Kennedy CM, Kennedy JW, Stabler CL, Hao E, Sambanis A, Simpson NE, Constantinidis L Biochemical and Biophysical Research Communications, 319(2), 569, 2004 |
10 |
Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material Cheng SY, Gross J, Sambanis A Biotechnology and Bioengineering, 87(7), 863, 2004 |